No photo of Laura Heiser

View Scopus Profile

Laura Heiser

Assistant Professor

  • 6013 Citations
  • 24 h-Index
20052019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Laura Heiser is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Annot: A Django-based sample, reagent, and experiment metadata tracking system

Bucher, E., Claunch, C. J., Hee, D., Smith, R. L., Devlin, K., Thompson, W., Korkola, J. E. & Heiser, L. M., Nov 1 2019, In : BMC bioinformatics. 20, 1, 542.

Research output: Contribution to journal › Article

Open Access

    • BET bromodomain inhibition blocks the function of a critical AR-independent master regulator network in lethal prostate cancer

    Coleman, D. J., Gao, L., King, C. J., Schwartzman, J., Urrutia, J., Sehrawat, A., Tayou, J., Balter, A., Burchard, J., Chiotti, K. E., Derrick, D. S., Sun, D., Xia, Z., Heiser, L. & Alumkal, J., Jan 1 2019, In : Oncogene.

    Research output: Contribution to journal › Article

    • 1 Scopus citations

    Maintenance of MYC expression promotes de novo resistance to BET bromodomain inhibition in castration-resistant prostate cancer

    Coleman, D. J., Gao, L., Schwartzman, J., Korkola, J., Sampson, D., Derrick, D. S., Urrutia, J., Balter, A., Burchard, J., King, C. J., Chiotti, K. E., Heiser, L. & Alumkal, J., Dec 1 2019, In : Scientific Reports. 9, 1, 3823.

    Research output: Contribution to journal › Article

    Open Access
    • 3 Scopus citations

    Systems biology approaches to measure and model phenotypic heterogeneity in cancer

    Meyer, A. S. & Heiser, L. M., Oct 2019, In : Current Opinion in Systems Biology. 17, p. 35-40 6 p.

    Research output: Contribution to journal › Review article

    Open Access
    • 1 Scopus citations

    Targeting the Mevalonate Pathway to Overcome Acquired Anti-HER2 Treatment Resistance in Breast Cancer

    Sethunath, V., Hu, H., De Angelis, C., Veeraraghavan, J., Qin, L., Wang, N., Simon, L. M., Wang, T., Fu, X., Nardone, A., Pereira, R., Nanda, S., Griffith, O. L., Tsimelzon, A., Shaw, C., Chamness, G. C., Reis-Filho, J. S., Weigelt, B., Heiser, L. M., Hilsenbeck, S. G. & 5 others, Huang, S., Rimawi, M. F., Gray, J. W., Osborne, C. K. & Schiff, R., Nov 1 2019, In : Molecular cancer research : MCR. 17, 11, p. 2318-2330 13 p.

    Research output: Contribution to journal › Article

    • 3 Scopus citations